Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-048491
Filing Date
2025-04-01
Accepted
2025-04-01 16:05:12
Documents
1
Period of Report
2025-03-29

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3901
  Complete submission text file 0000950170-25-048491.txt   5548
Mailing Address 2617 BISSONNET ST SUITE 233 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 233 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Issuer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MUSCLE MAKER, INC, 2200 SPACE PARK DRIVE,SUITE 310 HOUSTON TX 77058
Business Address
Groenewald Ferdinand (Reporting) CIK: 0001734018 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 25799587